Bringing Clarity to the Automated Lab
A Self-Healing Lab? | Lab Sync David Dambman Co‑Founder & Chief Innovation Officer, Lab Sync A Self‑Healing Lab? On a quiet Labor Day, one autonomous mobile robot, full agentic AI control, and ten hours of unsupervised runtime. What happened next reshaped how we think about lab automation. On Labor Day,
No matter how many instruments you add to an arm-based system, the throughput ceiling stays. One arm. One plate. One sequence. The arm is always the constraint. Here is what changes when you remove it. The Arm Bottleneck Explained In a traditional robotic workcell, every plate waits for the arm
The mobile robot sitting in the corner of a lab is not a myth. It is one of the most consistent things we hear from the lab automation community. A lab invests in mobile automation with high expectations: faster sample transport, freed-up researcher time, a step toward the automated lab
As a community, we usually talk about innovation in terms of technology. However, behind every technology breakthrough is a company made of people, processes, and capabilities that drives it forward. While we have not discussed this extensively in public, Lab Sync is not pursuing innovation in technology alone. We are
SAN DIEGO, CA – September 3, 2025 – Lab Sync, a leader in lab automation consulting and innovative technology solutions, today announced the appointment of Landon Diaz as Chief Operating Officer (COO), effective immediately. In his new role, Diaz will be responsible for leading company-wide operations strategy, ensuring customer value
For decades, the laboratory automation landscape has been predominantly shaped by powerful, yet stationary, robotic arms. These systems, often bolted to a bench, are synonymous with precision and efficiency within a confined workspace. However, the inherent nature of a scientific laboratory is one of constant flux and dynamic movement. Samples
Artificial Intelligence (AI) is no longer a futuristic fantasy; it’s rapidly becoming a transformative force in life science R&D. From accelerating drug discovery to optimizing experimental design and uncovering novel insights from complex datasets, the potential of AI is immense. However, for many R&D departments and IT professionals in the
The life sciences landscape is a whirlwind of innovation. Breakthroughs in genomics, personalized medicine, and novel therapeutics are happening at an unprecedented pace. But for many growing biotech and pharmaceutical companies, the very processes meant to drive these discoveries are becoming bottlenecks. Manual handoffs, siloed data, and inflexible workflows are